ContractShared Care Agreement • November 1st, 2019
Contract Type FiledNovember 1st, 2019SHARED CARE AGREEMENT Name of medicine Lisdexamfetamine (CNS Stimulant) single use not in combination Indication For Children (aged 6 years and over) and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) Version: 1 Approval date: August 2019 Review date: August 2021